ArticleGenetica2026
Signatures of high-altitude adaptation in Caucasus populations: evidence from the EGLN1-SPRTN locus.
Article in Genetica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
High-altitude hypoxia refers to the state of reduced oxygen availability experienced at high elevations, which poses significant physiological challenges. Genetic adaptations to this condition involve mutations in various genes that regulate oxygen sensing, erythropoiesis, and metabolic processes, enabling populations indigenous to high-altitude regions to maintain adequate tissue oxygenation and metabolic function under chronic hypoxic conditions. The aim of the study was to investigate the 1q42.2 region in populations of the Caucasus to identify alleles that may contribute to evolutionary adaptation. We studied a ~ 700 kb region within the 1q42.2 locus in Caucasus populations using the integrated selection of alleles favored by evolution (iSAFE) method. The study included 308 individuals from five ethnic groups inhabiting the high-altitude regions of the North Caucasus (Balkars, Ingush, Karachays, and Chechens) and the South Caucasus (Armenians). Whole-genome sequencing of the samples was performed on the DNBSEQ-T7 platform. The genomic region chr1:231046413–231,737,003 (GRCh38.p14) was selected due to its established role in high-altitude adaptation across various global populations. In the Balkar population, out of 120 informative variants analysed, 54 (45%) exceeded the iSAFE significance threshold of 0.1. Seven of these variants reached the maximum observed iSAFE score of 0.219, representing the strongest and most widespread signal of positive selection in this cohort. A similar pattern was observed in the Karachay population. Of the 123 informative variants analysed, 74 (60%) surpassed the threshold, with five variants sharing the highest score of 0.206. In contrast, the Ingush and Armenian cohorts each exhibited a single top-scoring candidate variant within the EGLN1 gene. In the Ingush population, 50 out of 79 informative variants exceeded the threshold, with the top variant scoring 0.182. Among Armenians, 36 of 80 variants passed the threshold, and the maximum iSAFE score was 0.193. Conversely, evidence for positive selection at this locus was minimal in the Chechen population. Although 152 informative variants were included in the analysis, only a single variant yielded an iSAFE score (0.105) that marginally exceeded the 0.1 threshold.
Indexed as
Identifiers
41543603What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.